by Lisa Willemse | Dec 6, 2013
> I’ve been thinking a lot about cancer lately: the mother of a good friend of mine is in the last stages of a terminal battle with pancreatic cancer and my godfather, a man with whom I share fond memories of practical jokes and summer farm vacations, was...
by Ben Paylor | Dec 5, 2013
> Just over two years ago I wrote about early reports from Dr. Roberto Bolli et al.’s SCIPIO trial running out of the University of Louisville in collaboration with the Harvard Medical School. Since this time, much has happened in the realm of cell therapy to treat...
by Nick Dragojlovic | Dec 2, 2013
> As the expiration of the California Institute for Regenerative Medicine’s (CIRM) funding approaches, the fate of CIRM after 2017 is top of mind for stem cell researchers in the state. While the agency’s leadership appears to be leaning towards some form of...
by Stacey Johnson | Nov 29, 2013
. Science as art is not a new concept. Google the term and you’ll see 2,330,000 hits. Princeton University has been holding an art-science competition since 2005 and the organizers have received hundreds of images from within the university community. The 2013 winners...
by Alessandra Pasut | Nov 28, 2013
> There’s no better pleasure in life than to satisfy our own cravings. Whether it’s a food craving or something else, there’s no peace for the soul, at least mine, till that need is quenched. And for those of us who find themselves longing for (more) stem cells,...
by Mark Curtis | Nov 27, 2013
. Welcome to the regenerative medicine deal review for the month of November. Cytori Therapeutics and Lorem Vascular have teamed up to catalyze the commercialization of Cytori cell therapies using its proprietary Celution® System in Asia. There was also a notable deal...
by Sara M. Nolte | Nov 26, 2013
> In honour of Movember – men’s health awareness month – I’m going to talk about prostate cancer. Not in the usual way – PSA (prostate-specific antigen) screens and clinical exams – but rather, from the perspective of cancer stem cells (CSCs), and their role in...
by Mark Curtis | Nov 19, 2013
. Welcome to October’s Update from the Clinic. Interesting developments this past month included the release of Phase 1/2a data from Living Cell Technologies that provides a first look at the safety and efficacy of its DIABECELL® product. We also saw an approval for...
by Stacey Johnson | Nov 15, 2013
. Sometimes too much choice can be a bad thing. It paralyzes you. I was flummoxed by the many options available to me in selecting what to feature on Right Turn this week. Then it struck me: I have the perfect item right under my nose (so to speak). CCRM just launched...
by Lisa Willemse | Nov 14, 2013
> We’re walking a little taller today. And carrying some silver, thanks to a Canadian Online Publishing Award handed out to Signals Blog last night in Toronto. Okay, it’s not real silver, but we’re very proud of our win under best blog in the...
Comments